tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TOVX Stock Latest News

Theriva Biologics files to sell 7.69M shares of common stock, warrants
The FlyTheriva Biologics files to sell 7.69M shares of common stock, warrants
2M ago
TOVX
Theriva Biologics Advances VCN-01 with FDA Guidance
PremiumCompany Announcements
Theriva Biologics Advances VCN-01 with FDA Guidance
2M ago
8K
TOVX
Theriva Biologics announces U.S. FDA guidance of Phase 3 study design
PremiumThe Fly
Theriva Biologics announces U.S. FDA guidance of Phase 3 study design
2M ago
TOVX
Theriva Biologics Highlights Key Achievements in Q3 2024
PremiumCompany Announcements
Theriva Biologics Highlights Key Achievements in Q3 2024
2M ago
TOVX
Theriva Biologics price target lowered to $6 from $25 at Maxim
PremiumThe Fly
Theriva Biologics price target lowered to $6 from $25 at Maxim
2M ago
TOVX
Theriva Biologics reports Q3 EPS ($6.81) vs. ($4.85) last year
PremiumThe FlyTheriva Biologics reports Q3 EPS ($6.81) vs. ($4.85) last year
2M ago
TOVX
3 Penny Stocks to Watch Now, 11/5/24
Premium
Market News
3 Penny Stocks to Watch Now, 11/5/24
3M ago
ATHA
TOVX
Theriva Biologics Expands Stock Plans and Share Authority
Premium
Company Announcements
Theriva Biologics Expands Stock Plans and Share Authority
3M ago
8K
TOVX
Theriva Biologics picked as finalist in competition for Merck KGaA’s EMEA grant
PremiumThe Fly
Theriva Biologics picked as finalist in competition for Merck KGaA’s EMEA grant
3M ago
TOVX
Theriva Biologics Gains Orphan Drug Status for VCN-01
PremiumCompany Announcements
Theriva Biologics Gains Orphan Drug Status for VCN-01
3M ago
8K
TOVX
Theriva announces orphan medicinal product designation by EMA to VCN-01
PremiumThe Fly
Theriva announces orphan medicinal product designation by EMA to VCN-01
3M ago
TOVX
Theriva Biologics’ SYN-004 receives positive DSMC review in Phase 1/2 trial
PremiumThe Fly
Theriva Biologics’ SYN-004 receives positive DSMC review in Phase 1/2 trial
4M ago
TOVX
Theriva Biologics Advances SYN-004 in Clinical Trial
PremiumCompany AnnouncementsTheriva Biologics Advances SYN-004 in Clinical Trial
4M ago
8K
TOVX
Theriva Biologics prices $2.5M public offering at $1.75 per share
Premium
The Fly
Theriva Biologics prices $2.5M public offering at $1.75 per share
4M ago
TOVX
Theriva Biologics prices $2.5M public offering at $2.00 per share
Premium
The Fly
Theriva Biologics prices $2.5M public offering at $2.00 per share
4M ago
TOVX
Correct: Theriva Biologics prices $2.5M public offering at $1.75 per share
PremiumThe Fly
Correct: Theriva Biologics prices $2.5M public offering at $1.75 per share
4M ago
TOVX
Theriva Biologics Advances VCN-01 in VIRAGE Phase 2b Trial
PremiumCompany Announcements
Theriva Biologics Advances VCN-01 in VIRAGE Phase 2b Trial
4M ago
8K
TOVX
Theriva Biologics achieves target patient enrollment in VIRAGE Phase 2b trial
PremiumThe Fly
Theriva Biologics achieves target patient enrollment in VIRAGE Phase 2b trial
4M ago
TOVX
Theriva Biologics Secures Funding for Viral Therapy Innovation
PremiumCompany Announcements
Theriva Biologics Secures Funding for Viral Therapy Innovation
4M ago
8K
TOVX
Theriva Biologics awarded manufacturing funding from Spanish government
PremiumThe FlyTheriva Biologics awarded manufacturing funding from Spanish government
4M ago
TOVX
Theriva Biologics files to sell 2.17M shares of common stock, warrants
Premium
The Fly
Theriva Biologics files to sell 2.17M shares of common stock, warrants
5M ago
TOVX
Theriva Biologics (TOVX) Is Making Noise With a Promising Pipeline
Premium
Market News
Theriva Biologics (TOVX) Is Making Noise With a Promising Pipeline
5M ago
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >